Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. | President and CEO, Director | Common Stock | 242K | $16.2M | $67.00 | Dec 3, 2024 | Direct |
Janux Therapeutics, Inc. | President and CEO, Director | Stock Option (right to buy) | 357K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JANX | Janux Therapeutics, Inc. | Dec 3, 2024 | 1 | -$1.01M | 4 | Dec 3, 2024 | President and CEO, Director |
JANX | Janux Therapeutics, Inc. | Nov 25, 2024 | 2 | -$1.29M | 4 | Nov 27, 2024 | President and CEO, Director |
JANX | Janux Therapeutics, Inc. | Oct 28, 2024 | 2 | -$1.34M | 4 | Oct 30, 2024 | President and CEO, Director |
JANX | Janux Therapeutics, Inc. | Sep 27, 2024 | 3 | -$1.16M | 4 | Sep 27, 2024 | President and CEO, Director |
JANX | Janux Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 3, 2024 | President and CEO, Director |
JANX | Janux Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Executive Officer, Director |
JANX | Janux Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Executive Officer, Director |
JANX | Janux Therapeutics, Inc. | Jun 10, 2021 | 0 | $0 | 3 | Jun 10, 2021 | Chief Executive Officer, Director |